These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 12421823)

  • 1. Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.
    Dumont N; Bakin AV; Arteaga CL
    J Biol Chem; 2003 Jan; 278(5):3275-85. PubMed ID: 12421823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility.
    Ueda Y; Wang S; Dumont N; Yi JY; Koh Y; Arteaga CL
    J Biol Chem; 2004 Jun; 279(23):24505-13. PubMed ID: 15044465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine and exogenous transforming growth factor beta control cell cycle inhibition through pathways with different sensitivity.
    Wang J; Sergina N; Ko TC; Gong J; Brattain MG
    J Biol Chem; 2004 Sep; 279(38):40237-44. PubMed ID: 15271980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteinase-activated receptor 2 promotes TGF-β-dependent cell motility in pancreatic cancer cells by sustaining expression of the TGF-β type I receptor ALK5.
    Zeeh F; Witte D; Gädeken T; Rauch BH; Grage-Griebenow E; Leinung N; Fromm SJ; Stölting S; Mihara K; Kaufmann R; Settmacher U; Lehnert H; Hollenberg MD; Ungefroren H
    Oncotarget; 2016 Jul; 7(27):41095-41109. PubMed ID: 27248167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta.
    Ungefroren H; Groth S; Ruhnke M; Kalthoff H; Fändrich F
    J Biol Chem; 2005 Jan; 280(4):2644-52. PubMed ID: 15546867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of transforming growth factor (TGF)-beta1-induced extracellular matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542.
    Laping NJ; Grygielko E; Mathur A; Butter S; Bomberger J; Tweed C; Martin W; Fornwald J; Lehr R; Harling J; Gaster L; Callahan JF; Olson BA
    Mol Pharmacol; 2002 Jul; 62(1):58-64. PubMed ID: 12065755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein 22 (HSPB8) limits TGF-β-stimulated migration of osteoblasts.
    Yamamoto N; Tokuda H; Kuroyanagi G; Kainuma S; Matsushima-Nishiwaki R; Fujita K; Kozawa O; Otsuka T
    Mol Cell Endocrinol; 2016 Nov; 436():1-9. PubMed ID: 27396899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways.
    Kakonen SM; Selander KS; Chirgwin JM; Yin JJ; Burns S; Rankin WA; Grubbs BG; Dallas M; Cui Y; Guise TA
    J Biol Chem; 2002 Jul; 277(27):24571-8. PubMed ID: 11964407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1/ALK5-induced monocyte migration involves PI3K and p38 pathways and is not negatively affected by diabetes mellitus.
    Olieslagers S; Pardali E; Tchaikovski V; ten Dijke P; Waltenberger J
    Cardiovasc Res; 2011 Aug; 91(3):510-8. PubMed ID: 21478266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses.
    Itoh S; Thorikay M; Kowanetz M; Moustakas A; Itoh F; Heldin CH; ten Dijke P
    J Biol Chem; 2003 Feb; 278(6):3751-61. PubMed ID: 12446693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-beta-mediated mast cell migration depends on mitogen-activated protein kinase activity.
    Olsson N; Piek E; Sundström M; ten Dijke P; Nilsson G
    Cell Signal; 2001 Jul; 13(7):483-90. PubMed ID: 11516623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A kinase-defective transforming growth factor-beta receptor type II is a dominant-negative regulator for human breast carcinoma MCF-7 cells.
    Ko Y; Koli KM; Banerji SS; Li W; Zborowska E; Willson JK; Brattain MG; Arteaga CL
    Int J Oncol; 1998 Jan; 12(1):87-94. PubMed ID: 9454891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
    Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
    Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.
    Watanabe H; de Caestecker MP; Yamada Y
    J Biol Chem; 2001 Apr; 276(17):14466-73. PubMed ID: 11278290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity.
    Bhowmick NA; Zent R; Ghiassi M; McDonnell M; Moses HL
    J Biol Chem; 2001 Dec; 276(50):46707-13. PubMed ID: 11590169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor.
    Fanayan S; Firth SM; Butt AJ; Baxter RC
    J Biol Chem; 2000 Dec; 275(50):39146-51. PubMed ID: 10993898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer cells. A novel mechanism for subversion of TGF-beta-induced mitoinhibition.
    Han C; Demetris AJ; Liu Y; Shelhamer JH; Wu T
    J Biol Chem; 2004 Oct; 279(43):44344-54. PubMed ID: 15294900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel permissive role of epidermal growth factor in transforming growth factor beta (TGF-beta) signaling and growth suppression. Mediation by stabilization of TGF-beta receptor type II.
    Song K; Krebs TL; Danielpour D
    J Biol Chem; 2006 Mar; 281(12):7765-74. PubMed ID: 16428382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of Src in transforming growth factor-ß regulation of growth arrest, epithelial-to-mesenchymal transition and cell migration in pancreatic ductal adenocarcinoma cells.
    Ungefroren H; Sebens S; Groth S; Gieseler F; Fändrich F
    Int J Oncol; 2011 Mar; 38(3):797-805. PubMed ID: 21225226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.